Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Nearing retirement at 50? Discover wealth management strategies tailored to secure your financial future effectively.
21,324 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
The U.S. government remains locked in a turf fight between the Treasury and Commerce Departments over who should over...
Delve into the investing philosophy of Bill Miller IV, the CIO and PM behind Miller Value Fund. Learn how high-convic...
Bitcoin faces a looming quantum threat as experts warn Q-Day could arrive around 2030. Galaxy Digital's up-to-$5 mill...
Across a century and a half, Western Union has defined cross-border payments. Yet fintech competition and shifting co...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
A fresh pullback can create smart entry points. This guide highlights my top 3 financial stocks after latest market p...
Could Tesla ride a $10 trillion wave of opportunity before 2029? This analysis breaks down the bets, the risks, and p...
As earnings season unfolds, fidelity national (fnf) earnings headlines can be complex. This article breaks down the n...
Analysts lean bullish on Apollo Global Management after a flurry of dealmaking, with elevated price targets and visib...
Csenge Advisory Group boosted its stake in the First Trust LMBS ETF during Q4, signaling confidence in short-duration...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...